Dr. Gormley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10
Bethesda, MD 20892Phone+1 301-496-9320
Education & Training
National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 2008 - 2010- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2008
University of MarylandResidency, Internal Medicine, 2003 - 2006
The University of Toledo College of MedicineClass of 2003
Certifications & Licensure
MD State Medical License 2006 - 2026
Clinical Trials
- Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Start of enrollment: 2012 Mar 02
- Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome Start of enrollment: 2011 Jan 29
Publications & Presentations
PubMed
- 18 citationsFDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma.Andrea C Baines, Rachel Ershler, Bindu Kanapuru, Qing Xu, Guoxiang Shen
Clinical Cancer Research. 2022-11-01 - 30 citationsMinimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.Kenneth C. Anderson, Daniel Auclair, Stacey J Adam, Amit Agarwal, Melissa Anderson
Clinical Cancer Research. 2021-07-28 - 12 citationsEligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials.Bindu Kanapuru, Laura L Fernandes, Andrea Baines, Rachel Ershler, Vishal Bhatnagar
Blood. 2023-07-20
Abstracts/Posters
- FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug RegimensNicole J. Gormley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bro...Nicole J. Gormley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
FDA Panel Puts PI3K Inhibitors for Blood Cancers on NoticeApril 22nd, 2022- FDA’s Cancer Advisory Committee to Evaluate Safety of PI3K InhibitorsApril 20th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
